GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (FRA:LOBE) » Definitions » Float Percentage Of Total Shares Outstanding

Lobe Sciences (FRA:LOBE) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Lobe Sciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lobe Sciences's float shares is 0.00 Mil. Lobe Sciences's total shares outstanding is 192.65 Mil. Lobe Sciences's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lobe Sciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lobe Sciences's Institutional Ownership is 0.31%.

Lobe Sciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lobe Sciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/192.65
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (FRA:LOBE) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TSXV:XRTX XCNQ:ASEP TSXV:IOT TSXV:RKV TSXV:MRVL TSX:APS TSXV:IBO TSX:APLI XCNQ:NURL XCNQ:MYND VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
LOBEF:USA LOBE:Canada
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Website
https://www.lobesciences.com
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines